Position in BLLN
as of Mar 31, 2026
· filed May 11, 2026
Position Value
$337,863
-$16,422 QoQ
Shares Held
4,280
-1.1% QoQ
Ownership
0.009%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Dec 2025
2 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in BLLN Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Mar 31, 2026Pathstone Holdings, LLC holds $130,287,723 across 21 Diagnostics & Research names. BLLN ranks #19 (0.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | DHR |
Danaher Corp /De/
|
189,279 | $35,887,297 | |
| 2 | TMO |
Thermo Fisher Scientific Inc.
|
70,197 | $34,503,930 | |
| 3 | IDXX |
Idexx Laboratories Inc /De
|
19,494 | $10,953,482 | |
| 4 | DGX |
Quest Diagnostics Inc
|
31,677 | $6,208,057 | |
| 5 | NTRA |
Natera, Inc.
|
24,436 | $4,886,954 | |
| 6 | ILMN |
Illumina, Inc.
|
39,311 | $4,845,472 | |
| 7 | GH |
Guardant Health, Inc.
|
52,092 | $4,811,737 | |
| 8 | MTD |
Mettler Toledo International Inc/
|
2,941 | $3,709,188 |
All Filings in BLLN
Export CSV
2 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $337,863 | 4,280 | Shares | Sole | 2026-05-11 | |
| 2025-12-31 | $354,285 | 4,329 | Shares | Sole | 2026-02-13 | |
| No filing history on record for this holder in this stock. | ||||||